Homology Medicines Inc. (FIXX)
NASDAQ: FIXX
· Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM
Homology Medicines Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.03M | 311K | -18.45M | 1.03M | -16.12M | -32.95M | -35.04M | -28.84M | -34.3M | -33.73M | -29.09M | 92.11M | -33.58M | -30.61M | -30.5M | -1.07M |
Depreciation & Amortization | 48K | -192K | -105K | 29K | n/a | 136K | 217K | 225K | 296K | 321K | 328K | 348K | 2.07M | 2.1M | 2.1M | 2.08M |
Stock-Based Compensation | 1.34M | 1.42M | 1.87M | 417K | 847K | 1.71M | 2.4M | 2.37M | 3.09M | 2.77M | 3.14M | 4.05M | 4.66M | 4.23M | 4.47M | 3.88M |
Other Working Capital | n/a | 8.25M | 6.97M | n/a | -6.97M | -1.28M | 3.51M | -4.56M | 6.74M | 2.92M | -854K | -4.47M | -2.9M | 460K | -1.82M | -35.06M |
Other Non-Cash Items | n/a | -21.72M | -22.82M | n/a | 5.24M | 365K | 364K | 2.27M | 668K | 1.71M | 1.69M | -130.42M | 322K | 300K | 290K | 279K |
Deferred Income Tax | n/a | 5.13M | 7.8M | n/a | -7.8M | 2.67M | 5.13M | n/a | n/a | n/a | n/a | n/a | 357K | 250K | 252K | 168K |
Change in Working Capital | n/a | 8.41M | 11.54M | n/a | -11.54M | 3.13M | 3.27M | -2.07M | 3.04M | 3.99M | -6.92M | 3.23M | -4.26M | -1.65M | -727K | -35.16M |
Operating Cash Flow | -12.48M | -6.65M | -20.16M | -14.55M | -21.57M | -24.94M | -23.66M | -26.05M | -27.2M | -24.93M | -30.85M | -30.68M | -30.43M | -25.39M | -24.11M | -29.82M |
Capital Expenditures | n/a | -75K | -411K | n/a | 338K | -338K | n/a | -228K | -9K | -6K | -121K | -1.15M | -338K | -477K | -764K | -817K |
Cash Acquisitions | n/a | -554K | -216K | n/a | 216K | 338K | n/a | -31.6M | -130M | n/a | n/a | 130M | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | 47.96M | n/a | n/a | n/a | -47.96M | 1K | -25.28M | n/a | -108.21M | -49.25M | -130M | -1K | 1K | -12.97M | -84.42M |
Sales Maturities Of Investments | n/a | -36.45M | -11.6M | 97K | 31.5M | 24.86M | 61M | 56.88M | 18M | n/a | 8M | 39.46M | 44M | 5M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 338K | n/a | -31.38M | 338K | 61M | 31.6M | 130M | -108.21M | -41.25M | 130M | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 10.88M | -11.89M | 97K | 31.72M | -22.76M | 61M | 31.37M | 17.99M | -108.22M | -41.37M | 168.31M | 43.66M | 4.52M | -13.74M | -85.23M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -4.21M | -4.53M | 99.35M | 14K | 18K | 2K | 150K | 32K | 124K | n/a | 440K | 1K | 379K | 49.75M | 2.04M |
Financial Cash Flow | n/a | -4.24M | -4.54M | 99.35M | 14K | 18K | 2K | 150K | 32K | 124K | n/a | 440K | 1K | 379K | 49.75M | 2.04M |
Net Cash Flow | -12.48M | -37.54M | -26.43M | 84.89M | 10.15M | -47.69M | 37.34M | 5.47M | -9.18M | -133.03M | -72.22M | 138.07M | 13.23M | -20.48M | 11.9M | -113.02M |
Free Cash Flow | -12.48M | -6.72M | -20.57M | -14.55M | -21.24M | -25.28M | -23.66M | -26.28M | -27.21M | -24.94M | -30.97M | -31.83M | -30.77M | -25.86M | -24.88M | -30.64M |